• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Cellebrite DI Ltd.

    2/10/22 4:00:46 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email
    SC 13G 1 tm225969d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. ___)*

     

    Cellebrite DI Ltd.
    (Name of Issuer)
     
    Ordinary shares, par value of NIS 0.00001 per share
    (Title of Class of Securities)
     
    M2197Q107
    (CUSIP Number)
     
    December 31, 2021
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)

     

    ¨ Rule 13d-1(c)

     

    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No. M2197Q107  

     

    1 Names of Reporting Persons
    SUNCORPORATION
    2 Check the appropriate box if a member of a Group (see instructions)
    (a)  ¨
    (b)  
    ¨
    3 Sec Use Only
     
    4 Citizenship or Place of Organization
    Japan

    Number of

    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:

    5 Sole Voting Power
    95,597,718
    6 Shared Voting Power
    0
    7 Sole Dispositive Power
    95,597,718
    8 Shared Dispositive Power
     
    9 Aggregate Amount Beneficially Owned by Each Reporting Person
    95,597,718
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
    ¨
    11 Percent of class represented by amount in row (9)
    51.1%
    12 Type of Reporting Person (See Instructions)
    HC
           

    Page 2 of 5

     

     

    Item 1.

     

    (a)Name of Issuer: Cellebrite DI Ltd.

     

    (b)Address of Issuer’s Principal Executive Offices: 94 Shlomo Shmelzer Road Petah Tikva 4970602, Israel

     

    Item 2.

     

    (a)Name of Person Filing: SUNCORPORATION

     

    (b)Address of Principal Business Office or, if None, Residence: Asahi 250 Kochino-cho Konan-shi Aichi-ken Zip code 483-8555

     

    (c)Citizenship:       Japan

     

    (d)Title and Class of Securities: Ordinary shares, par value of NIS 0.00001 per share

     

    (e)CUSIP No.:         M2197Q107

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨     Broker or dealer registered under Section 15 of the Act;

     

    (b)¨     Bank as defined in Section 3(a)(6) of the Act;

     

    (c)¨     Insurance company as defined in Section 3(a)(19) of the Act;

     

    (d)¨     Investment company registered under Section 8 of the Investment Company Act of 1940;

     

    (e)¨     An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    (f)¨     An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    (g)¨     A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

    (h)¨     A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i)¨     A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

     

    (j)¨     A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

     

    (k)¨     Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution:            

     

    Page 3 of 5

     

     

    Item 4.Ownership

     

    (a)Amount Beneficially Owned: 95,597,718 ordinary shares

     

    (b)Percent of Class: 51.1%

     

    (c)Number of shares as to which such person has:

      

    (i)Sole power to vote or to direct the vote: 95,597,718 ordinary shares

     

    (ii)Shared power to vote or to direct the vote: 0 ordinary share

     

    (iii)Sole power to dispose or to direct the disposition of: 95,597,718 ordinary shares

     

    (iv)Shared power to dispose or to direct the disposition of: 0 ordinary share

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

     

    Item 6.Ownership of more than Five Percent on Behalf of Another Person. Not applicable

     

    Item 7.Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. Not applicable

     

    Item 8.Identification and classification of members of the group. Not applicable

     

    Item 9.Notice of Dissolution of Group. Not applicable

     

    Item 10.Certifications. Not applicable

     

    Page 4 of 5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated:  February 10th, 2022

     

    SUNCORPORATION   
       
    By : /s/ Yoshimi Kimura  
    Name : Yoshimi Kimura  
    Title : Representative and Executive Managing Director  

     

    Page 5 of 5

     

    Get the next $CLBT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Financials

    Live finance-specific insights

    See more
    • Cellebrite Names David Barter Chief Financial Officer

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, acco

      7/8/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Announces First-Quarter 2025 Results

      First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue ARR grew 23% to $408.0 million First-Quarter 2025 adjusted EBITDA of $23.7 million, 22.0% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2025. "Cellebrite delivered strong 23% ARR growth while pairing solid revenue expansion with prudent spending to drive 34% year-over-year growth in adjusted EBITDA and a 22% margin," stated Thomas

      5/14/25 7:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    SEC Filings

    See more
    • SEC Form 6-K filed by Cellebrite DI Ltd.

      6-K - Cellebrite DI Ltd. (0001854587) (Filer)

      7/8/25 8:45:10 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Cellebrite DI Ltd.

      6-K - Cellebrite DI Ltd. (0001854587) (Filer)

      6/5/25 7:45:01 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Cellebrite DI Ltd.

      144 - Cellebrite DI Ltd. (0001854587) (Subject)

      5/23/25 4:19:11 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cellebrite Names David Barter Chief Financial Officer

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, acco

      7/8/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Accelerating Child Exploitation Investigations: Cellebrite Integrates Data from the National Center for Missing and Exploited Children (NCMEC)

      TYSONS CORNER, Va., June 24, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the expansion of its relationship with the National Center for Missing and Exploited Children (NCMEC) that will help speed up investigations involving crimes against children. NCMEC's CyberTipline hash value list is now integrated within Cellebrite's flagship digital forensics software, Cellebrite Inseyets, allowing public safety agencies to immediately pinpoint known child sexual abuse material (CSAM) files – speeding up time to evidence and justice for victims and survivors of abuse. The hash value l

      6/24/25 4:01:00 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Acquire Corellium

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. This combination will set a new standard for digital investigations and the security of smart devices including iOS, Android, automotive systems and any Arm-based IoT device. Customers across public safety, defense, intelligence and private sectors will benefit from: Accelerated identification of mobile vulnerabilities and exploitsIndustry-first ability to visualize and interact with virtual dev

      6/5/25 7:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Cellebrite DI with a new price target

      Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

      3/28/24 8:25:08 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by William Blair

      William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

      3/13/24 7:29:30 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by BofA Securities with a new price target

      BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

      2/16/24 7:23:02 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    See more
    • Cellebrite to Acquire Corellium

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. This combination will set a new standard for digital investigations and the security of smart devices including iOS, Android, automotive systems and any Arm-based IoT device. Customers across public safety, defense, intelligence and private sectors will benefit from: Accelerated identification of mobile vulnerabilities and exploitsIndustry-first ability to visualize and interact with virtual dev

      6/5/25 7:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

      1/6/25 8:00:00 AM ET
      $CLBT
      $CSCO
      Computer Software: Prepackaged Software
      Technology
      Computer Communications Equipment
      Telecommunications
    • Yossi Carmil to Step Down as CEO After Nearly 20 Years

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to

      11/6/24 8:20:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      9/17/24 4:33:52 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      8/29/24 6:07:01 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

      SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/12/24 12:38:56 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology